Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jesús Brenes"'
Autor:
Sandra Llop, Maria Plana, Sara Tous, Angelica Ferrando-Díez, Jesús Brenes, Marc Juarez, Zara Vidales, Esther Vilajosana, Isabel Linares, Lorena Arribas, Maria Duch, Marta Fulla, Aina Brunet, Alicia Lozano, Beatriz Cirauqui, Ricard Mesía, Marc Oliva
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectivesAnti-PD-(L)1 agents changed the landscape of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treatment. Previous studies showed improved response rates to salvage chemotherapy (SCT) after progression to anti-PD-(L)
Externí odkaz:
https://doaj.org/article/d28979b34c654b3691bc6bfc78e1d85b
Autor:
Sara Hijazo‐Pechero, Ania Alay, David Cordero, Raúl Marín, Noelia Vilariño, Ramón Palmero, Jesús Brenes, Aina Montalban‐Casafont, Ernest Nadal, Xavier Solé
Publikováno v:
Molecular Oncology, Vol 18, Iss 2, Pp 453-470 (2024)
Lung adenocarcinoma (LUAD) is a molecularly heterogeneous disease. In addition to genomic alterations, cancer transcriptional profiling can be helpful to tailor cancer treatment and to estimate each patient's outcome. Transcriptional activity levels
Externí odkaz:
https://doaj.org/article/1746702d23ca4a7aaf187ced7aa7e7a9
Autor:
Sara Hijazo‐Pechero, Ania Alay, David Cordero, Raúl Marín, Noelia Vilariño, Ramón Palmero, Jesús Brenes, Ernest Nadal, Xavier Solé
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 9, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/1cedf6f76fde47388f86c361169743ee
Autor:
Manuel Sánchez Cánovas, David Fernández Garay, Laura Ortega Moran, Jaime Rubio Pérez, Carlos Miguel Guirao Rubio, Miriam Lobo de Mena, Berta Obispo Portero, Jesús Brenes Castro, Yolanda Lage, Diego Cacho Lavin, Ana Belen Rupérez Blanco, Ana Manuela Martín Fernández de Soignie, Jonatan Zacarías Benoit Perejón, Laura Jiménez Colomo, Noel Blaya Boluda, Javier Bosque Moreno, Teresa Quintanar Verduguez, Carmen Rosa Garrido, Roberto Martín Huertas, Carme Font i Puig, Andrés Jesús Muñoz Martín
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Purpose Immune Checkpoint Inhibitors (ICI) can be associated with thrombotic events, both venous and arterial (VTE/AT). However, there is a paucity of information regarding patients in routine clinical practice. Methods/patients Retrospective, multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f1da92331c7ed655dc25fdec3c7e41
https://doi.org/10.1007/s12094-022-02860-5
https://doi.org/10.1007/s12094-022-02860-5
Autor:
Carla Marco, Marta Simó, Montse Alemany, Carlos Casasnovas, Raúl Domínguez, Noelia Vilariño, Mariona Calvo, Juan Martín-Liberal, Jesús Brenes, Joan Sabater-Riera, Jordi Bruna, Roser Velasco
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 130
Immunotherapy with immune checkpoint inhibitors (ICIs) have been reported to induce de novo or exacerbate pre-existing Myasthenia Gravis (MG). We present a single center case series of patients who developed an immune-related myasthenia gravis (irMG)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841ad521c26ca717f64a98abb53634a9
https://doi.org/10.3390/jcm12010130
https://doi.org/10.3390/jcm12010130
Publikováno v:
Current Opinion in Oncology. 31:160-168
Purpose of review The systemic therapies available in recurrent and metastatic head and neck squamous cell carcinoma to date are palliative-intent treatments in most cases. However, a small subgroup of patients derives unconventional benefit and beco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23bd10dbe0519ab679311d017c7639a5
https://doi.org/10.1097/cco.0000000000000530
https://doi.org/10.1097/cco.0000000000000530
Autor:
Alberto Hernando-Calvo, Milica Stefanovic, Shao Hui Huang, Jesús Brenes Castro, Jie Su, Brian O'Sullivan, Jolie Ringash, Alicia Lozano, Beatriz Cirauqui, Ezra Hahn, Iris Teruel, John R de Almeida, Jordi Marruecos, Ian Witterick, Jordi Rubió-Casadevall, David Paul Goldstein, Lillian L. Siu, John Waldron, Anna Spreafico, Marc Oliva
Publikováno v:
Journal of Clinical Oncology. 40:6092-6092
6092 Background: Sinonasal cancers (SC) are heterogeneous diseases. Despite multimodality treatment, overall survival (OS) remains unsatisfactory. We aimed to identify prognostic factors (PFs) associated with patterns of failure and OS in non-metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79f888d160db5cbc99d7ef575be5691b
https://doi.org/10.1200/jco.2022.40.16_suppl.6092
https://doi.org/10.1200/jco.2022.40.16_suppl.6092
Autor:
Cánovas, Manuel Sánchez, Garay, David Fernández, Moran, Laura Ortega, Pérez, Jaime Rubio, Rubio, Carlos Miguel Guirao, de Mena, Miriam Lobo, Portero, Berta Obispo, Castro, Jesús Brenes, Lage, Yolanda, Lavin, Diego Cacho, Blanco, Ana Belen Rupérez, de Soignie, Ana Manuela Martín Fernández, Perejón, Jonatan Zacarías Benoit, Colomo, Laura Jiménez, Boluda, Noel Blaya, Moreno, Javier Bosque, Verduguez, Teresa Quintanar, Garrido, Carmen Rosa, Huertas, Roberto Martín, Puig, Carme Font i
Publikováno v:
Clinical & Translational Oncology; Oct2022, Vol. 24 Issue 10, p2010-2020, 11p
Autor:
Marc Oliva Bernal, Jesús Brenes Castro, Alicia Lozano, Marta Fulla, Sandra Llop Serna, Maria Teresa Plana, Mireia Melero, Miren Taberna, Victoria Gomez Garcia, Ricard Mesia, Macarena Honorato, Montse Goma, Maite Antonio Rebollo, Oriol Bermejo, Clara Ejarque Martinez, M. Esther Vilajosana Altamis, Isabel Linares
Publikováno v:
Journal of Clinical Oncology. 39:6057-6057
6057 Background: Up to 24% of patients (pts) newly-diagnosed with LA-HNSCC are 70 years old (yo). NCCN guidelines recommend a geriatric assessment to guide treatment decisions in this pts population. Comprehensive geriatric assessment (CGA) of older
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::738a335f0f2528c346a35be601886e07
https://doi.org/10.1200/jco.2021.39.15_suppl.6057
https://doi.org/10.1200/jco.2021.39.15_suppl.6057
Autor:
Francisca Morey Cortes, Pau Guillen Sentis, Alicia Lozano, Maria Teresa Plana, Marc Oliva Bernal, Jesús Brenes Castro, Beatriz Quirós, Maria Labori Trias, Miren Taberna, Isabel Linares, Sara Tous, Antonio Mari Roig, Ricard Mesia, M. Esther Vilajosana Altamis, Jordi Tornero Salto, Carmen Castillo Manzano, Victoria Gomez Garcia, Montse Goma, Laia Alemany, Oriol Bermejo
Publikováno v:
Journal of Clinical Oncology. 39:6061-6061
6061 Background: Treatment (ttm) of cancer patients (pts) was compromised during the first wave of COVID19 pandemic due to collapse of healthcare systems. Standard of care (SOC) for LA-HNSCC pts had to be adapted as operating rooms were temporarily u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed753fe17fac3e933251bcd030242b48
https://doi.org/10.1200/jco.2021.39.15_suppl.6061
https://doi.org/10.1200/jco.2021.39.15_suppl.6061